Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Fine Chemical Intermediates sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN115557948A details a metal-free electrochemical method for C3 selenization, offering green synthesis and cost reduction for pharmaceutical intermediate manufacturing.
Patent CN110655456B details Co-catalyzed hydrogenation of E/Z mixed olefins. Offers high ee and conversion for pharmaceutical intermediates.
Novel copper-catalyzed route for 4 4 diamino diphenyl ether offers mild conditions and high purity ensuring reliable supply chain stability and cost efficiency.
Novel aniline-based route for 4,4'-diaminodiphenyl ether. Reduces cost and pollution. Reliable supply for polymer and pharma applications.
Patent CN116283699B reveals a visible-light driven method for high-purity fluoroalkyl pyrrolidines offering significant cost reduction in pharmaceutical intermediates manufacturing and supply chain reliability.
Patent CN106397163A reveals novel dichlorination route offering significant cost reduction and supply chain reliability for high-purity pharmaceutical intermediate manufacturing globally.
Patent CN102746260A details an eco-friendly synthesis of benzofuran-2(3H)-one using silica sulfonic acid. This method offers high conversion, catalyst recyclability, and reduced waste for pharma intermediates.
Novel copper-catalyzed cyclization of allenes and isonitriles offers mild conditions for high-purity pyrrole intermediates, ensuring supply chain stability.
Patent CN101906083B details a green synthesis of 2-amino-6-nitrobenzothiazole using acidic ionic liquids, offering high purity and reduced waste for reliable dye intermediate suppliers.
Patent CN113061091B reveals a green Cu-Co/Al2O3 catalytic route for N-alkylation. Offers cost reduction and high purity for pharmaceutical intermediates manufacturing.
Patent CN115557887B reveals a mild Ugi reaction route for trifluoromethyl pyridine derivatives. This method offers significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel patent CN105254611B enables waste-to-value synthesis. Reduces toxic waste and enhances supply chain reliability for pharmaceutical intermediates.
Patent CN102977033B enables low-temperature copper-catalyzed synthesis. Delivers high stereoselectivity and scalable production for global pharmaceutical supply chains.
Patent CN116023271B details a high-yield p-fluoroaniline synthesis using Ni-Ag catalysts, offering significant cost reduction and supply reliability for pharmaceutical intermediate manufacturing.
Novel palladium-catalyzed synthesis of fluorovinylphosphonates offers high stereoselectivity and yield, enabling cost-effective production of enzyme inhibitor intermediates.
Patent CN101602681A details a solvent-free Ni(OAc)2 catalyzed route for beta-enaminones, offering high purity and eco-friendly processing for pharmaceutical intermediates.
Patent CN110862362B reveals ethyl acetate crystallization for high purity. Offers supply chain stability and cost efficiency for vitamin intermediate manufacturing partners.
Patent CN117003692B enables green synthesis of difluoromethyl 2-pyridyl sulfone. Reduces cost and waste for pharmaceutical intermediate manufacturing supply chains.
Patent CN112079803A details high-purity 4-halophthalic anhydride synthesis. Offers supply chain reliability and cost advantages for global pharmaceutical and flame retardant manufacturers.
Patent CN107935882B reveals a mild Bronsted acid catalyzed route for high-purity azo compounds, offering significant cost reduction and supply chain reliability for global pharmaceutical manufacturers.